No Record Found
Sector
PharmaceuticalsOpen
₹508.7Prev. Close
₹509.65Turnover(Lac.)
₹939.2Day's High
₹515Day's Low
₹503.1552 Week's High
₹564.0552 Week's Low
₹312Book Value
₹141.48Face Value
₹10Mkt Cap (₹ Cr.)
4,675.81P/E
25.95EPS
19.47Divi. Yield
0.22 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
15 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
29 Jan 2025
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 04 Feb, 2025
The consolidated net profit of the company increased 1.1% YoY at ₹37.1 crore from ₹36.7 crore that was reported for the same quarter last year.
Aarti Drugs shares has witnessed a 8% dip in the last one year, and 10% dip in the last six months.
Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Bank of Baroda, HDFC Bank, etc.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 91.27 | 91.94 | 92.6 | 92.6 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,160.08 | 1,083.27 | 1,021.7 | 879.57 |
Net Worth | 1,251.35 | 1,175.21 | 1,114.3 | 972.17 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,251.17 | 1,914.89 | 1,634.92 | 1,140.45 |
yoy growth (%) | 17.56 | 17.12 | 43.35 | 4.75 |
Raw materials | -1,480.52 | -1,139.91 | -1,045.87 | -700.52 |
As % of sales | 65.76 | 59.52 | 63.97 | 61.42 |
Employee costs | -69.31 | -69.28 | -60.09 | -50.48 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 255.49 | 337.48 | 166.59 | 112.21 |
Depreciation | -47.39 | -47.59 | -46.66 | -37.79 |
Tax paid | -60.5 | -80 | -39.3 | -38.8 |
Working capital | 194.84 | 155.99 | 28.06 | 98.02 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 17.56 | 17.12 | 43.35 | 4.75 |
Op profit growth | -20.7 | 64.17 | 34.4 | 3.66 |
EBIT growth | -23.47 | 81.13 | 36.89 | 2.07 |
Net profit growth | -24.33 | 89.94 | 84.81 | -2.73 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 2,387.03 | 2,528.58 | 2,716.05 | 2,488.65 | 2,154.78 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,387.03 | 2,528.58 | 2,716.05 | 2,488.65 | 2,154.78 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 16.36 | 4.03 | 2.19 | 11.32 | 4.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,616.6 | 77.85 | 3,87,792.51 | 753.53 | 0.99 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,026.5 | 68.48 | 1,59,985.97 | 557 | 0.5 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,574.6 | 24.61 | 1,27,124.34 | 1,303.13 | 1.02 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,566.2 | 60.71 | 1,20,694.38 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,316.7 | 15.94 | 1,09,867.7 | 2,961.2 | 0.61 | 7,788.7 | 345.75 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
CMD & Executive Director
Prakash M Patil
ED / MD / Promoter
Rashesh C Gogri
ED / Joint MD / Promoter
Harshit M Savla
E D & Wholetime Director
Harit P Shah
WTD & Executive Director
Uday M Patil
Non Executive Director
Narendra Jagannath Salvi
Independent Non Exe. Director
Ankit Vikram Paleja
Independent Non Exe. Director
Bhaskar Narayan Thorat
Independent Non Exe. Director
Neha Gada
Independent Non Exe. Director
Hasmukh Dedhia
Independent Non Exe. Director
Sandeep Madhusudan Joshi
Independent Non Exe. Director
Shri Ajit E. Venugopalan
Company Sec. & Compli. Officer
Rushikesh V Deole
Chairman Emeritus
Chandrakant V. Gogri
Plot No N-198 MIDC Tarapur,
Pamtembhi Village Palghar Tal,
Maharashtra - 401506
Tel: 91-22-24072249
Website: http://www.aartidrugs.com
Email: investorrelations@aartidrugs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglo...
Read More
Reports by Aarti Drugs Ltd
What is the Aarti Drugs Ltd share price today?
What is the Market Cap of Aarti Drugs Ltd?
What is the PE and PB ratio of Aarti Drugs Ltd?
What is the 52 Week High and Low of Aarti Drugs Ltd?
What is the CAGR of Aarti Drugs Ltd?
What is the shareholding pattern of Aarti Drugs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
